ProMIS Neurosciences, Inc.
General ticker "PMN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $22.4M (TTM average)
ProMIS Neurosciences, Inc. does not follow the US Stock Market performance with the rate: -5.4%.
Estimated limits based on current volatility of 6.4%: low 11.58$, high 13.17$
Factors to consider:
- Total employees count: 7 (+16.7%) as of 2023
- Top business risk factors: Inability to raise capital, Product development risks, Market acceptance, Regulatory and compliance, Pandemic risks
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.09$, 13.67$]
- 2026-12-31 to 2027-12-31 estimated range: [4.22$, 11.39$]
Short-term PMN quotes
Long-term PMN plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $40.17MM |
| Operating Income | $-40.17MM |
| Non-Operating Income | $0.45MM |
| R&D Expense | $33,379.32MM |
| Income(Loss) | $-39.72MM |
| Profit(Loss)* | $-39,719.15MM |
| Stockholders Equity | $-1.26MM |
| Assets | $9,182.42MM |
| Operating Cash Flow | $-28,118.58MM |
| Investing Cash Flow | $-0.70MM |
| Financing Cash Flow | $20,944.67MM |
| Earnings Per Share** | $-22.61 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.